Hypersensitivity reactions to ophthalmic products

Maria Teresa Ventura, M. Viola, F. Gaeta, E. Di Leo, R. Buquicchio, A. Romano

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Adverse reactions after administration of ophthalmic products have frequently been observed. These reactions can be provoked by both active principles and excipients. Different pathogenic mechanisms have been suggested for such reactions, including immunologic ones. Basophils and mast cells participate in IgE-mediated reactions through the release of mediators like histamine and tryptase, whereas a T-cell-mediated pathogenic mechanism is involved in most delayed reactions, particularly conjunctival ones and eyelid dermatitis. Prick tests and immediate-reading intradermal tests are carried out to diagnose immediate hypersensitivity reactions, while patch tests are usually performed to evaluate delayed reactions. Other diagnostic tests, such as serum-specific IgE assays in immediate reactions, as well as delayed-reading intradermal tests and/or lymphocyte transformation tests in delayed ones, are rarely performed. In this review, particular attention is addressed to the clinical and practical aspects of both cell-mediated and IgE-mediated hypersensitivity reactions to ophthalmic products.

Original languageEnglish
Pages (from-to)3401-3410
Number of pages10
JournalCurrent Pharmaceutical Design
Volume12
Issue number26
DOIs
Publication statusPublished - Sep 2006

Fingerprint

Intradermal Tests
Immediate Hypersensitivity
Immunoglobulin E
Reading
Hypersensitivity
Ophthalmic Administration
Tryptases
Patch Tests
Basophils
Excipients
Dermatitis
Eyelids
Lymphocyte Activation
Routine Diagnostic Tests
Mast Cells
Histamine
T-Lymphocytes
Serum

Keywords

  • Eye drops
  • Hypersensitivity reactions
  • Ophthalmic products
  • Patch tests
  • Preservatives

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Ventura, M. T., Viola, M., Gaeta, F., Di Leo, E., Buquicchio, R., & Romano, A. (2006). Hypersensitivity reactions to ophthalmic products. Current Pharmaceutical Design, 12(26), 3401-3410. https://doi.org/10.2174/138161206778194024

Hypersensitivity reactions to ophthalmic products. / Ventura, Maria Teresa; Viola, M.; Gaeta, F.; Di Leo, E.; Buquicchio, R.; Romano, A.

In: Current Pharmaceutical Design, Vol. 12, No. 26, 09.2006, p. 3401-3410.

Research output: Contribution to journalArticle

Ventura, MT, Viola, M, Gaeta, F, Di Leo, E, Buquicchio, R & Romano, A 2006, 'Hypersensitivity reactions to ophthalmic products', Current Pharmaceutical Design, vol. 12, no. 26, pp. 3401-3410. https://doi.org/10.2174/138161206778194024
Ventura, Maria Teresa ; Viola, M. ; Gaeta, F. ; Di Leo, E. ; Buquicchio, R. ; Romano, A. / Hypersensitivity reactions to ophthalmic products. In: Current Pharmaceutical Design. 2006 ; Vol. 12, No. 26. pp. 3401-3410.
@article{4a46d708b9f44160ac97564c672ce296,
title = "Hypersensitivity reactions to ophthalmic products",
abstract = "Adverse reactions after administration of ophthalmic products have frequently been observed. These reactions can be provoked by both active principles and excipients. Different pathogenic mechanisms have been suggested for such reactions, including immunologic ones. Basophils and mast cells participate in IgE-mediated reactions through the release of mediators like histamine and tryptase, whereas a T-cell-mediated pathogenic mechanism is involved in most delayed reactions, particularly conjunctival ones and eyelid dermatitis. Prick tests and immediate-reading intradermal tests are carried out to diagnose immediate hypersensitivity reactions, while patch tests are usually performed to evaluate delayed reactions. Other diagnostic tests, such as serum-specific IgE assays in immediate reactions, as well as delayed-reading intradermal tests and/or lymphocyte transformation tests in delayed ones, are rarely performed. In this review, particular attention is addressed to the clinical and practical aspects of both cell-mediated and IgE-mediated hypersensitivity reactions to ophthalmic products.",
keywords = "Eye drops, Hypersensitivity reactions, Ophthalmic products, Patch tests, Preservatives",
author = "Ventura, {Maria Teresa} and M. Viola and F. Gaeta and {Di Leo}, E. and R. Buquicchio and A. Romano",
year = "2006",
month = "9",
doi = "10.2174/138161206778194024",
language = "English",
volume = "12",
pages = "3401--3410",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "26",

}

TY - JOUR

T1 - Hypersensitivity reactions to ophthalmic products

AU - Ventura, Maria Teresa

AU - Viola, M.

AU - Gaeta, F.

AU - Di Leo, E.

AU - Buquicchio, R.

AU - Romano, A.

PY - 2006/9

Y1 - 2006/9

N2 - Adverse reactions after administration of ophthalmic products have frequently been observed. These reactions can be provoked by both active principles and excipients. Different pathogenic mechanisms have been suggested for such reactions, including immunologic ones. Basophils and mast cells participate in IgE-mediated reactions through the release of mediators like histamine and tryptase, whereas a T-cell-mediated pathogenic mechanism is involved in most delayed reactions, particularly conjunctival ones and eyelid dermatitis. Prick tests and immediate-reading intradermal tests are carried out to diagnose immediate hypersensitivity reactions, while patch tests are usually performed to evaluate delayed reactions. Other diagnostic tests, such as serum-specific IgE assays in immediate reactions, as well as delayed-reading intradermal tests and/or lymphocyte transformation tests in delayed ones, are rarely performed. In this review, particular attention is addressed to the clinical and practical aspects of both cell-mediated and IgE-mediated hypersensitivity reactions to ophthalmic products.

AB - Adverse reactions after administration of ophthalmic products have frequently been observed. These reactions can be provoked by both active principles and excipients. Different pathogenic mechanisms have been suggested for such reactions, including immunologic ones. Basophils and mast cells participate in IgE-mediated reactions through the release of mediators like histamine and tryptase, whereas a T-cell-mediated pathogenic mechanism is involved in most delayed reactions, particularly conjunctival ones and eyelid dermatitis. Prick tests and immediate-reading intradermal tests are carried out to diagnose immediate hypersensitivity reactions, while patch tests are usually performed to evaluate delayed reactions. Other diagnostic tests, such as serum-specific IgE assays in immediate reactions, as well as delayed-reading intradermal tests and/or lymphocyte transformation tests in delayed ones, are rarely performed. In this review, particular attention is addressed to the clinical and practical aspects of both cell-mediated and IgE-mediated hypersensitivity reactions to ophthalmic products.

KW - Eye drops

KW - Hypersensitivity reactions

KW - Ophthalmic products

KW - Patch tests

KW - Preservatives

UR - http://www.scopus.com/inward/record.url?scp=33748544597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748544597&partnerID=8YFLogxK

U2 - 10.2174/138161206778194024

DO - 10.2174/138161206778194024

M3 - Article

VL - 12

SP - 3401

EP - 3410

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 26

ER -